Valiant Laboratories

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue47.4847.0753.0992.15116.15
Expenses45.0346.8056.0891.1189.96
EBITDA3.050.94-0.264.9930.12
Operating Profit2.520.42-2.312.0627.26
Profit Before Tax2.450.28-2.991.0526.19
Net Profit1.820.20-7.061.7621.10
Financial Ratios
Operating Profit Margin6.51%2.03%-0.50%5.41%26.13%
Net Profit Margin3.89%0.43%-13.46%1.91%18.30%
Earning Per Share (Diluted)0.420.04-1.300.353.89
Dividends Per Share0.000.000.000.000.00